Diabetes

After reviewing a series of studies involving hundreds of thousands of participants, a team of researchers found three eating plans that significantly reduced the development of type 2 diabetes. All are relatively easy to follow.

The fitness community regularly touts the health benefits of getting in 10,000 steps per day. But a new study says that a good deal fewer steps can still deliver significant benefits, including a 47% reduction in dying prematurely.

Adding to the growing body of evidence supporting the health benefits of cramming all your weekly exercise into two days, a large new study has found that it can significantly reduce the risk of cardiovascular mortality in adults with diabetes.

The US Food and Drug Administration has instructed all GLP-1 drug-makers to update warning labels to include the risk of serious kidney injury that can result from dehydration. This comes after cases of acute kidney injury have required hemodialysis.

The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite, has successfully completed its Phase I trial. In the trial, participants lost an average of 3% fat mass in two weeks.

Synching your daily calories with your own circadian rhythm can improve glucose metabolism, protecting against type 2 diabetes and obesity. A new study uncovers the relationship between metabolic health and our personal, inherent biological clock.

A new study reveals that Americans are confused about what “processed food” actually means, and which types pose health risks. Researchers found major gaps between public perception and science, highlighting the need for more comprehensive education.

Engineers at MIT have developed a coin-sized device that can be safely implanted in the body to automatically deliver a dose of glucagon when a sensor notices blood glucose levels dropping too low – and potentially save the user's life.

If you have a high level of interaction with patients, students, clients or the general public in your work, you might be at much higher risk of developing type 2 diabetes. And, if you also have poor support at work, it could worsen your odds further.

Over the weekend, Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing what appears to be a strategic "something for everyone" plan of attack from the pharmaceutical giant.

A novel weight loss drug in the same class as semaglutide has successfully met its targets in the largest clinical trial yet, with nearly 90% of participants losing at least 5% of their body weight. The results strengthen its case for FDA approval.

Diabetic foot ulcers are prone to recurring, even when they look healed. A new study used an existing method to assess the degree of water loss from the skin and found that it was a good diagnostic tool for predicting a foot ulcer’s comeback.